市場調査レポート

商品コード

敗血症診断薬の2028年までの市場予測-製品、技術、手法、検査タイプ、病原体、エンドユーザーごとの世界分析

Sepsis Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, Technology, Method, Test Type, Pathogen, and End User

出版日: 2022年12月29日 | 発行: The Insight Partners

| ページ情報: 英文 267 Pages | 納期: 1～5営業日

価格

PDF (Single User License)

USD 4,550 707,343円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Site License)

USD 6,550 1,018,263円

レポートPDFを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 8,550 1,329,183円

レポートPDFを企業内すべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=155.46円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

敗血症診断の世界市場は、2021年の6億6183万米ドルから2028年には12億2652万米ドルに達すると予測され、2021年から2028年までのCAGRは9.2％で成長するとみられています。院内感染の増加による敗血症の発生率の上昇や、製品上市の増加につながる迅速な診断テストの需要の高まりなどの要因が、敗血症診断市場の全体的な成長を後押ししています。しかし、熟練した専門家の不足が敗血症診断薬市場の成長を妨げています。

敗血症は、感染症に対する身体の極端な反応です。敗血症は、COVID-19やインフルエンザなどのウイルス感染症を含む他の感染症の結果として起こりうる重篤な臨床症状です。生命を脅かす医学的緊急事態です。敗血症を患う患者さんの予後を改善するためには、早期発見と具体的な臨床的介入が極めて重要です。細菌による敗血症は、細胞への酸素供給不足、細菌およびその粒子の除去に関与する免疫複合体の不活性化などの反応のカスケードを伴い、多臓器不全に進行します。敗血症は、多くの医師により、敗血症から始まり、重症敗血症を経て敗血症性ショックに至る3段階の症候群と考えられており、医療上の緊急事態とされています。敗血症は、死亡率、罹患率ともに高いのが特徴です。敗血症診断学とは、一般に細菌性の一次感染、あるいは頻度は低いが真菌および/またはウイルス性の感染に起因する重篤な臨床状態である敗血症を診断する学問です。2019年2月にNational Center for Biotechnology Informationが発表した論文によると、敗血症の死亡率は25 %～30 %とされています。

敗血症の診断検査の多くは時間がかかり、結果が出るまで最大72時間かかります。あらゆる疾病を分子で診断する時代において、敗血症の迅速診断検査に対する需要は高まっています。その結果、業界で活動する多くの主なプレーヤーは、革新的な敗血症の迅速診断テストの開発に力を注いでいます。例えば、2020年9月、バルセロナに本拠を置くLoop Diagnosticsは、ポイントオブケア診断プラットフォームを発売しました。このプラットフォームは、従来の血液培養分析の方法を代替し、迅速な結果を提供します。また、血液ベースのマーカーによって細菌感染を特定し、99%の正確さで2時間以内に検査結果を提供することができます。さらに、2020年5月、Beckman Coulterは、早期敗血症指標を搭載した新しい血液分析装置DxH 690Tを米国で発売しました。

さらに、敗血症診断に関連するあらゆる課題を克服するため、主な企業が費用対効果の高い診断検査を開発しました。例えば、分子診断薬のパイオニアであるInflammatix社は、同社のHostDxTM Sepsisテストの使用が標準的な方法と比較して費用対効果が高いことを示す医療経済モデルを発表しています。この検査は、救急外来で急性呼吸器感染症（ARTI）が疑われる患者を対象に実施されました。この調査は、2020年4月にThe Journal of Health Economics and Outcomes Researchに掲載されました。このモデルは、HostDx Sepsisテストを広く採用することで臨床的および経済的なメリットが期待できることを病院の臨床医に知らせました。

さらに、敗血症の迅速診断に対するニーズの高まりが、近年の主要企業の研究活動に拍車をかけました。敗血症診断の既存企業と新興企業の両方が、政府や研究機関から財政的に十分な支援を受けています。例えば、2020年4月、Cytovale Inc.は、COVID-19を含む呼吸器感染症患者の敗血症診断のためにBiomedical Advanced Research and Development Authority（BARDA）と提携しました。この調査は590万米ドルに上り、BARDAが約383万米ドルを拠出すると推定されています。このように、効果的な治療法の発売と進行中の臨床試験は、予測期間中に敗血症診断市場に有利な機会を提供するでしょう。

敗血症診断の世界市場は、製品、技術、方法、検査タイプ、病原体、エンドユーザーに基づいて区分されます。製品に基づき、敗血症診断市場は、機器、試薬およびアッセイ、血液培養メデューム、ソフトウェアに区分されます。血液培養液セグメントは、2021年から2028年の間に最大の市場シェアを占めると推定されます。Journal of the Academy of Clinical Microbiologistsのレポートによると、血液培養液は、敗血症の原因菌の特定、経験的および特異的抗生物質の適切な選択、感染の焦点を特定するためのさらなる調査への指針を可能にするので、敗血症管理における最も重要な調査の1つであり続けているとのことです。すべての敗血症患者には、血液培養が推奨されます。血液培養システムの自動化により、患者管理の改善と救命のために、可能な限り短時間で最大限の病原体の採取が可能になりました。この方法は、敗血症患者の診断ワークアップにおいて最高レベルのエビデンスを明らかにするため、非常に推奨されています。このような前述の要因は、血液培養液セグメントの市場成長を支え、最終的に敗血症診断市場の成長を促進します。

ソフトウェアセグメントは、予測期間中に敗血症診断市場全体で最も高いCAGRを記録すると予想されます。敗血症診断の世界市場に関わるいくつかのトップ企業は、市場の最前線に留まるために様々なソフトウェアを継続的に発表しています。例えば、モバイルテクノロジー社は、敗血症や患者の生命を脅かす症状の早期発見に重要な役割を果たす「Nerve center Software」を発表しました。この新しいソフトウェアは、バイタルサインと病理結果を用いて敗血症の早期診断を自動化し、敗血症のリスクが確認された場合には、適切な医師や看護師にモバイルデバイスで直ちに警告を発することができます。

敗血症診断の世界市場に関するレポート作成にあたり、世界保健機関（WHO）、疾病対策予防センター（CDC）、国立医学図書館、国立生物工学情報センター（NCBI）など、一次情報および二次情報を参照しました。

調査対象範囲
インサイトパートナーズの調査報告書ガイダンス
市場セグメンテーション
- 敗血症診断薬の世界市場-製品別
- 敗血症診断薬の世界市場-技術別
- 敗血症診断薬の世界市場-方法別
- 敗血症診断の世界市場-検査タイプ別
- 敗血症診断薬の世界市場（病原体別
- 敗血症診断薬の世界市場-エンドユーザー別
- 敗血症診断薬の世界市場-地域別

第2章重要なポイント

第3章調査手法

対象範囲
2次調査
1次調査

第4章敗血症診断薬市場- 市場情勢

PEST分析
- 北米PEST分析
- 欧州PEST分析
- アジア太平洋地域のPEST分析
- 中東・アフリカPEST分析
- 中南米PEST分析
専門家の見解

第5章敗血症診断市場- 主な市場力学

市場促進要因
- 院内感染の増加別敗血症の発症率の高さ
- 迅速な診断テストに対する需要の高まりと製品の上市の増加
市場抑制要因
- 熟練した専門家の不足
市場機会
- 敗血症診断研究への資金援助と支援の増加
今後の動向
- 敗血症診断における技術的進歩の高まり
影響分析

第6章敗血症診断薬市場-世界分析

敗血症診断薬の世界市場の収益予測と分析
- 世界の敗血症診断薬市場の収益予測と分析
- 主要プレイヤーの市場ポジショニング
- 敗血症診断薬の世界市場-市場ポテンシャル分析、地域別
比較企業分析
- 成長戦略分析
- 主要プレイヤーの業績
  - バイオメリュー社
  - Danaher
- 敗血症診断薬市場のマーケットシェア分析

第7章：敗血症診断薬の世界市場収益と2028年までの予測-製品別

敗血症診断薬の世界市場、製品別、2021年・2028年（%）
機器
試薬およびアッセイ
血液培養培地
ソフトウェア

第8章敗血症診断薬市場の収益と2028年までの予測（技術編

敗血症診断薬の世界市場技術別シェア-2021年・2028年（%）
分子生物学的診断法
フローサイトメトリー
- リアルタイム細胞解析
  - TaqMan-Based Multiplex RT PCRおよび血液培養
  - レジーナ・マルゲリータ小児病院（イタリア、トリノ）で実施されたMagicplex（TM）Sepsis Real-Time Tests-Case Study
  - 敗血症診断ソリューションの提供企業
  - リアルタイムPCR別敗血症診断
  - 次世代シーケンサーの新手法と技術の進歩・革新
  - インピーダンス測定別リアルタイム細胞解析
マイクロフルイディクス
イムノアッセイ
バイオマーカー
- メタボロミクス
  - 敗血症におけるメタボロームプロファイル
  - 敗血症診断におけるメタボロミクスの普及・利用形態
  - メタボロームプロファイリング別敗血症の早期予知
  - 敗血症の診断と治療におけるオミックスの今後の役割
  - 敗血症のバイオマーカーと診断ツール
  - 敗血症におけるメタボロミクス・プロテオミクスの役割
  - 急性腎不全の予後を予測する低分子バイオマーカー探索の可能性
  - 敗血症診断におけるメタボロミクスの最新応用例
  - ミトコンドリア機能におけるメタボロミクス
  - ミトコンドリア医学の診断におけるメタボロミクスの大きな可能性
微生物学

第9章敗血症診断の市場収益と2028年までの予測- 方法

敗血症診断薬世界市場メソッド別シェア-2021年・2028年（%）
自動診断法
従来型診断法

第10章敗血症診断薬市場の収益と2028年までの予測（検査タイプ別

敗血症診断薬の世界市場：検査タイプ別シェア-2021年・2028年（%）
ポイントオブケア検査
ラボラトリー検査

第11章敗血症診断薬市場の収益と2028年までの予測- 病原体

敗血症診断薬世界市場病原体別シェア-2021年・2028年（%）
細菌性敗血症
真菌性敗血症
その他

第12章敗血症診断薬市場の収益と2028年までの予測（エンドユーザー編

敗血症診断薬の世界市場エンドユーザー別シェア-2021年・2028年（%）
病院
病理学およびリファレンスラボラトリー
その他

第13章敗血症診断の世界市場の収益と2028年までの予測-地域別分析

北米
- バイオマーカー
- フローサイトメトリー
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- その他の欧州
アジア太平洋地域
- 中国
- 日本
- インド
- オーストラリア
- 韓国
- その他アジア太平洋地域
中東・アフリカ地域
- UAE
- サウジアラビア
- 南アフリカ共和国
- その他中東・アフリカ地域
中南米

図表

List Of Tables

Table 1. New next-generation sequencing techniques by Company
Table 2. North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 3. North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 4. North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
Table 5. North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 6. North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 7. North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
Table 8. North America Sepsis Diagnostics Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 9. US Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 10. US Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 11. US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
Table 12. US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 13. US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 14. US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
Table 15. US Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 16. Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 17. Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 18. Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
Table 19. Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 20. Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 21. Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
Table 22. Canada Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 23. Mexico Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 24. Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 25. Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
Table 26. Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 27. Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 28. Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
Table 29. Mexico Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 30. Europe: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 31. Europe: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
Table 32. Europe: Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
Table 33. Europe: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
Table 34. Europe: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 35. Europe: Sepsis Diagnostics Market, by Pathogen- Revenue and Forecast to 2028 (US$ Million)
Table 36. Europe: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 37. Germany: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 38. Germany: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
Table 39. Germany: Sepsis Diagnostics Market, by Molecular diagnostics - Revenue and Forecast to 2028 (US$ Million)
Table 40. Germany: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
Table 41. Germany: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 42. Germany: Sepsis Diagnostics Market, by Pathogen- Revenue and Forecast to 2028 (US$ Million)
Table 43. Germany: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 44. France: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 45. France: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
Table 46. France: Sepsis Diagnostics Market, by Molecular diagnostics - Revenue and Forecast to 2028 (US$ Million)
Table 47. France: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
Table 48. France: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 49. France: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
Table 50. France: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 51. UK: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 52. UK: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
Table 53. UK: Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
Table 54. UK: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
Table 55. UK: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 56. UK: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
Table 57. UK: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 58. Italy: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 59. Italy: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
Table 60. Italy: Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
Table 61. Italy: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
Table 62. Italy: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 63. Italy: Sepsis Diagnostics Market, by Pathogen- Revenue and Forecast to 2028 (US$ Million)
Table 64. Italy: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 65. Spain: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 66. Spain: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
Table 67. Spain: Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
Table 68. Spain: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
Table 69. Spain: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 70. Spain: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
Table 71. Spain: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 72. Rest of Europe: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 73. Rest of Europe: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
Table 74. Rest of Europe: Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
Table 75. Rest of Europe: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
Table 76. Rest of Europe: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 77. Rest of Europe: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
Table 78. Rest of Europe: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 79. Asia Pacific: Sepsis Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 80. Asia Pacific: Sepsis Diagnostics Market, by Technology- Revenue and forecast to 2028 (USD Million)
Table 81. Asia Pacific: Sepsis Diagnostics Market, by Method- Revenue and forecast to 2028 (USD Million)
Table 82. Asia Pacific: Sepsis Diagnostics Market, by Test Type- Revenue and forecast to 2028 (USD Million)
Table 83. Asia Pacific: Sepsis Diagnostics Market, by Pathogen - Revenue and forecast to 2028 (USD Million)
Table 84. Asia Pacific: Sepsis Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 85. China: Sepsis Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 86. China: Sepsis Diagnostics Market, by Technology- Revenue and forecast to 2028 (USD Million)
Table 87. China: Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and forecast to 2028 (USD Million)
Table 88. China: Sepsis Diagnostics Market, by Method- Revenue and forecast to 2028 (USD Million)
Table 89. China: Sepsis Diagnostics Market, by Test Type- Revenue and forecast to 2028 (USD Million)
Table 90. China: Sepsis Diagnostics Market, by Pathogen - Revenue and forecast to 2028 (USD Million)
Table 91. China: Sepsis Diagnostics Market, By End User- Revenue and Forecast to 2028 (USD Million)
Table 92. Japan: Sepsis Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 93. Japan: Sepsis Diagnostics Market, By Technology - Revenue and Forecast to 2028 (USD Million)
Table 94. Japan: Sepsis Diagnostics Market, By Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
Table 95. Japan: Sepsis Diagnostics Market, By Method - Revenue and Forecast to 2028 (USD Million)
Table 96. Japan: Sepsis Diagnostics Market, By Test Type - Revenue and Forecast to 2028 (USD Million)
Table 97. Japan: Sepsis Diagnostics Market, By Pathogen - Revenue and Forecast to 2028 (USD Million)
Table 98. Japan: Sepsis Diagnostics Market, By End User- Revenue and Forecast to 2028 (USD Million)
Table 99. India: Sepsis Diagnostics Market, By Product- Revenue and Forecast to 2028(USD Million)
Table 100. India: Sepsis Diagnostics Market, By Technology - Revenue and Forecast to 2028 (USD Million)
Table 101. India: Sepsis Diagnostics Market, By Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
Table 102. India: Sepsis Diagnostics Market, By Method - Revenue and Forecast to 2028 (USD Million)
Table 103. India: Sepsis Diagnostics Market, By Test Type - Revenue and Forecast to 2028 (USD Million)
Table 104. India: Sepsis Diagnostics Market, By Pathogen - Revenue and Forecast to 2028 (USD Million)
Table 105. India: Sepsis Diagnostics Market, By End User- Revenue and Forecast to 2028 (USD Million)
Table 106. Australia: Sepsis Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 107. Australia: Sepsis Diagnostics Market, By Technology - Revenue and Forecast to 2028 (USD Million)
Table 108. Australia: Sepsis Diagnostics Market, By Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
Table 109. Australia: Sepsis Diagnostics Market, By Method - Revenue and Forecast to 2028 (USD Million)
Table 110. Australia: Sepsis Diagnostics Market, By Test Type - Revenue and Forecast to 2028 (USD Million)
Table 111. Australia: Sepsis Diagnostics Market, By Pathogen - Revenue and Forecast to 2028 (USD Million)
Table 112. Australia: Sepsis Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 113. South Korea: Sepsis Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 114. South Korea: Sepsis Diagnostics Market, By Technology - Revenue and Forecast to 2028 (USD Million)
Table 115. South Korea: Sepsis Diagnostics Market, By Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
Table 116. South Korea: Sepsis Diagnostics Market, By Method - Revenue and Forecast to 2028 (USD Million)
Table 117. South Korea: Sepsis Diagnostics Market, By Test Type - Revenue and Forecast to 2028 (USD Million)
Table 118. South Korea: Sepsis Diagnostics Market, By Pathogen - Revenue and Forecast to 2028 (USD Million)
Table 119. South Korea: Sepsis Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 120. Rest of Asia Pacific: Sepsis Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 121. Rest of Asia Pacific: Sepsis Diagnostics Market, By Technology- Revenue and Forecast to 2028 (USD Million)
Table 122. Rest of Asia Pacific: Sepsis Diagnostics Market, By Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
Table 123. Rest of Asia Pacific: Sepsis Diagnostics Market, By Method- Revenue and Forecast to 2028 (USD Million)
Table 124. Rest of Asia Pacific: Sepsis Diagnostics Market, By Test Type- Revenue and Forecast to 2028 (USD Million)
Table 125. Rest of Asia Pacific: Sepsis Diagnostics Market, By Pathogen- Revenue and Forecast to 2028 (USD Million)
Table 126. Rest of Asia Pacific: Sepsis Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 127. Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million).
Table 128. Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 129. Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
Table 130. Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 131. Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 132. Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
Table 133. Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 134. UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 135. UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 136. UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
Table 137. UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 138. UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 139. UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
Table 140. UAE: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 141. Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 142. Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 143. Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
Table 144. Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 145. Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 146. Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
Table 147. Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 148. South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 149. South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 150. South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
Table 151. South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 152. South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 153. South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
Table 154. South Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 155. Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 156. Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 157. Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
Table 158. Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 159. Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 160. Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
Table 161. Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 162. South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 163. South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 164. South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
Table 165. South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 166. South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 167. South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
Table 168. South & Central America: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 169. Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 170. Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 171. Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
Table 172. Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 173. Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 174. Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
Table 175. Brazil: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 176. Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 177. Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 178. Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
Table 179. Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 180. Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 181. Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
Table 182. Argentina: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 183. Rest of South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 184. Rest of South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 185. Rest of South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
Table 186. Rest of South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 187. Rest of South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 188. Rest of South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
Table 189. Rest of South & Central America: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 190. Recent Organic Growth Strategies in Sepsis Diagnostics Market
Table 191. Inorganic Developments in the Sepsis Diagnostics Market
Table 192. Glossary of Terms

List Of Figures

Figure 1. Sepsis Diagnostics Market Segmentation
Figure 2. Sepsis Diagnostics Market, By Region
Figure 3. Global Sepsis Diagnostics Market Overview
Figure 4. Blood Culture Media Segment Held Largest Share of Type Segment in Sepsis Diagnostics Market
Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Sepsis Diagnostics Market, by Geography (US$ Million)
Figure 7. Global Sepsis Diagnostics Market- Leading Country Markets (US$ Million)
Figure 8. Global Sepsis Diagnostics Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East & Africa: PEST Analysis
Figure 13. South & Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Sepsis Diagnostics Market: Impact Analysis of Drivers and Restraints
Figure 16. Global Sepsis Diagnostics Market- Revenue Forecast and Analysis - 2020- 2028
Figure 17. Global Sepsis Diagnostics Market- Revenue Forecast and Analysis - 2021 - 2028
Figure 18. Market Positioning of Key Players in Global Sepsis Diagnostics Market
Figure 19. Global Sepsis Diagnostics market - Market Potential Analysis, By Region
Figure 20. Global Sepsis Diagnostics market - Comparative Company Analysis
Figure 21. Global Sepsis Diagnostics Market - Growth Strategy Analysis
Figure 22. Market Share Analysis of Key Players in Global Sepsis Diagnostics Market
Figure 23. Global Sepsis Diagnostics Market, by Product, 2021 & 2028 (%)
Figure 24. Instruments: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. Reagents and Assays: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. Blood Culture Media: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 27. Software: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 28. Global Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)
Figure 29. Molecular Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 30. Polymerase Chain Reaction: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 31. Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 32. Syndromic Panel-Based Testing: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 33. Microarrays: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 34. Flow Cytometry: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 35. Real-Time Cell Analysis: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 36. Microfluidics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 37. Immunoassay: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 38. Biomarkers: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 39. Metabolomics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 40. Microbiology: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 41. Global Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)
Figure 42. Automated Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 43. Conventional Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 44. Global Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)
Figure 45. Point-of-Care Tests: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 46. Laboratory Tests: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 47. Global Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)
Figure 48. Bacterial Sepsis: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 49. Fungal Sepsis: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 50. Others: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 51. Global Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)
Figure 52. Hospitals: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 53. Pathology and Reference Laboratories: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 54. Others: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 55. North America: Sepsis Diagnostics Market, by Key Country - Revenue (2021) (US$ Million)
Figure 56. North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 57. North America: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 58. US: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 59. Canada: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 60. Mexico: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 61. Europe: Sepsis Diagnostics Market, by Key Country - Revenue (2021) (US$ Million)
Figure 62. Europe: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 63. Europe: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 64. Germany: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 65. France: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 66. UK: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 67. Italy: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 68. Spain: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 69. Rest of Europe: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 70. Asia Pacific: Sepsis Diagnostics Market, by Key Country - Revenue (2021) (USD Million)
Figure 71. Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 72. Asia Pacific: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 73. China: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 74. Japan: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 75. India: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 76. Australia: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 77. South Korea: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 78. Rest of Asia Pacific: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 79. Middle East & Africa: Sepsis Diagnostics Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 80. Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 81. Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
Figure 82. UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 83. Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 84. South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 85. Rest of Middle East and Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 86. South and Central America Sepsis Diagnostics Market Revenue Overview, by Key Country, 2021 (US$ Million)
Figure 87. South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 88. South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
Figure 89. Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 90. Argentina Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 91. Rest of South & Central America: Sepsis Diagnostics Market- Revenue and Forecast to 2028 (US$ Mn)
Figure 92. Impact of COVID-19 Pandemic in North American Country Markets
Figure 93. Impact of COVID-19 Pandemic in European Country Markets
Figure 94. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 95. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 96. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets
Figure 97. Growth Strategies in the Sepsis Diagnostics Market (%)

Product Code: TIPHE100001391

The global sepsis diagnostics market is projected to reach US$ 1,226.52 million by 2028 from US$ 661.83 million in 2021; it is expected to grow at a CAGR of 9.2% from 2021 to 2028. Factors such as the rising incidence of sepsis due to increasing nosocomial infections and growing demand for rapid diagnostic tests leading to increasing product launches drive the overall growth of the sepsis diagnostics market. However, the lack of skilled professionals hampers the sepsis diagnostics market growth.

Sepsis is the body's extreme response to an infection. Sepsis is a serious clinical condition that can be a result of other infections, including viral infections, such as COVID-19 or influenza. It is a life-threatening medical emergency. Early detection and specific clinical intervention are crucial for improving the outcome of patients suffering from sepsis. Sepsis caused by bacteria involves cascade of reactions, such as lack of oxygen supply to cells and inactivation of immune complexes involved in the clearance of bacteria and its particles, which progresses to multiple organ failure. Sepsis is considered as a three staged syndrome by many physicians that starts with sepsis, leading to severe sepsis, and results in septic shock, which is considered as a medical emergency. Sepsis has a high mortality and morbidity rate. Sepsis diagnostics is the study of diagnosis of sepsis, which is a serious clinical condition that generally results from primary bacterial infection or, less frequently, from a fungal and/or viral infection. According to an article published by the National Center for Biotechnology Information in February 2019, the mortality rate of sepsis is 25 % to 30 %.

Most of the diagnostic tests for sepsis are time-consuming and take up to 72 hours to provide results. In the era of molecular diagnosis for every kind of disease, the demand for rapid diagnostic tests for sepsis is rising. As a result, many key players operating in the industry put efforts into developing innovative rapid diagnostic tests for sepsis. For instance, in September 2020, Barcelona-based Loop Diagnostics launched a point-of-care diagnosis platform. The platform replaces the traditional methods of blood culture analysis and provide rapid results. Also, it can identify bacterial infections via blood-based markers and provide test results in two hours with a 99% accuracy rate. Additionally, in May 2020, Beckman Coulter launched its new DxH 690T hematology analyzer with early sepsis indicators in the US.

Moreover, the key players developed cost-effective diagnostic tests to overcome all the challenges associated with sepsis diagnosis. For instance, Inflammatix, a pioneering molecular diagnostics company, published a health economic model that shows the use of the company's HostDxTM Sepsis test is cost-effective as compare to standard methods. The test was performed on patients suspected of acute respiratory tract infections (ARTI) in Emergency Departments. The study was published in April 2020 in The Journal of Health Economics and Outcomes Research. The model informed hospital clinicians of the potential clinical and economic benefits of widespread adoption of the HostDx Sepsis test.

Furthermore, the rising need for rapid diagnostics for sepsis fueled the research activities among key players in recent years. Both the existing players and the start-ups in sepsis diagnostics are well supported financially by government and research organizations. For instance, in April 2020, Cytovale Inc. partnered with the Biomedical Advanced Research and Development Authority (BARDA) for sepsis diagnosis in patients with respiratory infections, including COVID-19. The research was estimated to stand at US$ 5.9 million, with a contribution of approximately US$ 3.83 million by BARDA. Thus, the launch of effective treatments and ongoing clinical trials would provide lucrative opportunities for the sepsis diagnostics market during the forecast period.

The global sepsis diagnostics market is segmented on the basis of product, technology, method, test type, pathogen, and end user. Based on product, the sepsis diagnostics market is segmented into instruments, reagents and assays, blood culture media, and software. The blood culture media segment is estimated to account for the largest market share during 2021-2028. According to the Journal of the Academy of Clinical Microbiologists report, blood culture media remains one of the most critical investigations in the sepsis management as it allows identification of the responsible organism for sepsis, appropriate choice of empirical and specific antibiotics, and points toward further investigations for identifying the focus on infection. A blood culture media is recommended for all septic patients. Automation in the blood culture system has enabled maximum yield of pathogens in the shortest possible time to improve patient management and save lives. The method is highly recommended as it reveals one of the highest levels of evidence in the diagnostic workup of a sepsis patient. Such aforementioned factors support the market growth for the blood culture media segment and ultimately fuel the growth of sepsis diagnostics market.

The software segment is expected to register the highest CAGR for the overall sepsis diagnostics market during the forecast period. Several top players involved in the global sepsis diagnostics market continuously launch different software to stay forefront in the market. For instance, Mobile Technology announced the launch of Nerve center Software that play an important role in early detection of sepsis and other life-threatening conditions among patients. The new software uses vital signs and pathology results for automating the early diagnosis of sepsis and then ensures that the appropriate doctors and nurses are immediately alerted on their mobile devices when a risk of sepsis has been identified.

The World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), National Library of Medicine, and National Center for Biotechnology Information (NCBI) are among the primary and secondary sources referred to while preparing the report on the global sepsis diagnostics market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the sepsis diagnostics market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global sepsis diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Global Sepsis Diagnostics Market - By Product
- 1.3.2 Global Sepsis Diagnostics Market - By Technology
- 1.3.3 Global Sepsis Diagnostics Market - By Method
- 1.3.4 Global Sepsis Diagnostics Market - By Test Type
- 1.3.5 Global Sepsis Diagnostics Market - By Pathogen
- 1.3.6 Global Sepsis Diagnostics Market - By End User
- 1.3.7 Global Sepsis Diagnostics Market - By Geography

2. Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Sepsis Diagnostics Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
- 4.2.2 Europe PEST Analysis
- 4.2.3 Asia Pacific PEST Analysis
- 4.2.4 Middle East & Africa PEST Analysis
- 4.2.5 South & Central America PEST Analysis
4.3 Experts Opinion

5. Sepsis Diagnostics Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 High Incidence of Sepsis due to Increasing Nosocomial Infections
- 5.1.2 Rise in Demand for Rapid Diagnostic Tests Leading to Increasing Product Launches
5.2 Market Restraints
- 5.2.1 Lack of Skilled Professionals
5.3 Market Opportunities
- 5.3.1 Increase in Funding and Support for Sepsis Diagnostics Research
5.4 Future Trends
- 5.4.1 Rising Technological Advancements in Sepsis Diagnosis
5.5 Impact Analysis

6. Sepsis Diagnostics Market- Global Analysis

6.1 Global Sepsis Diagnostics Market Revenue Forecast and Analysis
- 6.1.1 Global Sepsis Diagnostics Market Revenue Forecast and Analysis
- 6.1.2 Market Positioning of Key Players
- 6.1.3 Global Sepsis Diagnostics market - Market Potential Analysis, By Region
6.2 Comparative Company Analysis
- 6.2.1 Growth Strategy Analysis
- 6.2.2 Performance of Key Players
  - 6.2.2.1 BioMerieux, Inc.
  - 6.2.2.2 Danaher
- 6.2.3 Market Share Analysis of Sepsis Diagnostics Market

7. Global Sepsis Diagnostics Market Revenue and Forecasts To 2028- by Product

7.1 Overview
7.2 Global Sepsis Diagnostics Market, By Product, 2021 & 2028 (%)
7.3 Instruments
- 7.3.1 Overview
- 7.3.2 Instruments: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Reagents and Assays
- 7.4.1 Overview
- 7.4.2 Reagents and Assays: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Blood Culture Media
- 7.5.1 Overview
- 7.5.2 Blood Culture Media: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Software
- 7.6.1 Overview
- 7.6.2 Software: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

8. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Technology

8.1 Overview
8.2 Global Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)
8.3 Molecular Diagnostics
- 8.3.1 Overview
- 8.3.2 Molecular Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  - 8.3.2.1 Polymerase Chain Reaction
    - 8.3.2.1.1 Overview
    - 8.3.2.1.2 Polymerase Chain Reaction: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  - 8.3.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization
    - 8.3.2.2.1 Overview
    - 8.3.2.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  - 8.3.2.3 Syndromic Panel-Based Testing
    - 8.3.2.3.1 Overview
    - 8.3.2.3.2 Syndromic Panel-Based Testing: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  - 8.3.2.4 Microarrays
    - 8.3.2.4.1 Overview
    - 8.3.2.4.2 Microarrays: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.4 Flow Cytometry
- 8.4.1 Overview
- 8.4.2 Flow Cytometry: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
- 8.4.3 Real-Time Cell Analysis
  - 8.4.3.1 TaqMan-Based Multiplex RT PCR and Blood Culture
    - 8.4.3.1.1 Characteristics of TaqMan Assays
  - 8.4.3.2 Magicplex (TM)Sepsis Real-Time Tests Performed in Tertiary Regina Margherita Children's Hospital (Turin, Italy) - Case Study
    - 8.4.3.2.1 Abstract
    - 8.4.3.2.2 Conclusion:
  - 8.4.3.3 Companies that are engaged in providing Sepsis Diagnostic solutions
  - 8.4.3.4 Sepsis diagnosis by real-time PCR
  - 8.4.3.5 New next-generation sequencing technique and technological advancements/innovations
  - 8.4.3.6 Real Time Cellular Analysis Using Impedance Measurements
- 8.4.4 Real-Time Cell Analysis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.5 Microfluidics
- 8.5.1 Overview
- 8.5.2 Microfluidics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.6 Immunoassay
- 8.6.1 Overview
- 8.6.2 Immunoassay: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7 Biomarkers
- 8.7.1 Overview
- 8.7.2 Biomarkers: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
- 8.7.3 Metabolomics
  - 8.7.3.1 Metabolite Profile in Sepsis
  - 8.7.3.2 Penetration/Usage Pattern of Metabolomics in Sepsis Diagnosis
  - 8.7.3.3 Early Prediction of Sepsis by Metabolite Profiling
  - 8.7.3.4 Future Role of Omics in Diagnosis and Therapy of Sepsis
    - 8.7.3.4.1 Genomics
    - 8.7.3.4.2 Proteomics
  - 8.7.3.5 Sepsis Biomarkers and Diagnostic Tools
  - 8.7.3.6 Role Metabolomics and Proteomics in Sepsis
  - 8.7.3.7 Potential Approach for Identifying Small Molecule Biomarkers for Acute Kidney Disease Prognosis
  - 8.7.3.8 Recent Application of Metabolomics in Sepsis Diagnosis
  - 8.7.3.9 Metabolics in Mitochondrial Function
  - 8.7.3.10 Substantial Potential of Metabolomics in Diagnostics for Mitochondrial Medicine
- 8.7.4 Metabolomics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.8 Microbiology
- 8.8.1 Overview
- 8.8.2 Microbiology: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Method

9.1 Overview
9.2 Global Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)
9.3 Automated Diagnostics
- 9.3.1 Overview
- 9.3.2 Automated Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.4 Conventional Diagnostics
- 9.4.1 Overview
- 9.4.2 Conventional Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Test Type

10.1 Overview
10.2 Global Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)
10.3 Point-of-Care Tests
- 10.3.1 Overview
- 10.3.2 Point-of-Care Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10.4 Laboratory Tests
- 10.4.1 Overview
- 10.4.2 Laboratory Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

11. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Pathogen

11.1 Overview
11.2 Global Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)
11.3 Bacterial Sepsis
- 11.3.1 Overview
- 11.3.2 Bacterial Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11.4 Fungal Sepsis
- 11.4.1 Overview
- 11.4.2 Fungal Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11.5 Others
- 11.5.1 Overview
- 11.5.2 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

12. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - End User

12.1 Overview
12.2 Global Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)
12.3 Hospitals
- 12.3.1 Overview
- 12.3.2 Hospitals: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12.4 Pathology and Reference Laboratories
- 12.4.1 Overview
- 12.4.2 Pathology and Reference Laboratories: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12.5 Others
- 12.5.1 Overview
- 12.5.2 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

13. Global Sepsis Diagnostics Market Revenue and Forecasts to 2028 - Geographical Analysis

13.1 North America: Sepsis Diagnostics Market
- 13.1.1 Overview
- 13.1.2 North America: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 13.1.3 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
- 13.1.4 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  - 13.1.4.1 Biomarkers: Metabolomics 2019-2028
  - 13.1.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
  - 13.1.4.3 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
- 13.1.5 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
- 13.1.6 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
- 13.1.7 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
- 13.1.8 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
- 13.1.9 North America: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
  - 13.1.9.1 US: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.1.9.1.1 Overview
    - 13.1.9.1.2 US: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.1.9.1.3 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    - 13.1.9.1.4 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
    - 13.1.9.1.4.1 Biomarkers: Metabolomics 2019-2028
    - 13.1.9.1.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.1.9.1.4.3 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
    - 13.1.9.1.5 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 13.1.9.1.6 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
    - 13.1.9.1.7 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
    - 13.1.9.1.8 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
  - 13.1.9.2 Canada: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.1.9.2.1 Overview
    - 13.1.9.2.2 Canada: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.1.9.2.3 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    - 13.1.9.2.4 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
    - 13.1.9.2.4.1 Biomarkers: Metabolomics 2019-2028
    - 13.1.9.2.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.1.9.2.4.3 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
    - 13.1.9.2.5 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 13.1.9.2.6 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
    - 13.1.9.2.7 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
    - 13.1.9.2.8 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
  - 13.1.9.3 Mexico: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.1.9.3.1 Overview
    - 13.1.9.3.2 Mexico: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.1.9.3.3 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    - 13.1.9.3.4 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
    - 13.1.9.3.4.1 Biomarkers: Metabolomics 2019-2028
    - 13.1.9.3.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.1.9.3.4.3 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
    - 13.1.9.3.5 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 13.1.9.3.6 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
    - 13.1.9.3.7 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
    - 13.1.9.3.8 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
13.2 Europe: Sepsis Diagnostics Market
- 13.2.1 Overview
- 13.2.2 Europe: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 13.2.3 Europe: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
- 13.2.4 Europe: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  - 13.2.4.1 Biomarkers: Metabolomics 2019-2028
  - 13.2.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
  - 13.2.4.3 Europe: Sepsis Diagnostics Market, by Molecular Diagnostics- Revenue and Forecast to 2028 (US$ Million)
- 13.2.5 Europe: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
- 13.2.6 Europe: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
- 13.2.7 Europe: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
- 13.2.8 Europe: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
- 13.2.9 Europe: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
  - 13.2.9.1 Germany: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.1.1 Overview
    - 13.2.9.1.2 Germany: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.1.3 Germany: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.1.4 Germany: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.1.4.1 Biomarkers: Metabolomics 2019-2028
    - 13.2.9.1.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.2.9.1.4.3 Germany: Sepsis Diagnostics Market, by Molecular diagnostics- Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.1.5 Germany: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.1.6 Germany: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.1.7 Germany: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.1.8 Germany: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 13.2.9.2 France: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.2.1 Overview
    - 13.2.9.2.2 France: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.2.3 France: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.2.4 France: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.2.4.1 Biomarkers: Metabolomics 2019-2028
    - 13.2.9.2.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.2.9.2.4.3 France: Sepsis Diagnostics Market, by Molecular diagnostics - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.2.5 France: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.2.6 France: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.2.7 France: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.2.8 France: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 13.2.9.3 UK: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.3.1 Overview
    - 13.2.9.3.2 UK: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.3.3 UK: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.3.4 UK: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.3.4.1 Biomarkers: Metabolomics 2019-2028
    - 13.2.9.3.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.2.9.3.4.3 UK: Sepsis Diagnostics Market, by Molecular Diagnostics- Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.3.5 UK: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.3.6 UK: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.3.7 UK: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.3.8 UK: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 13.2.9.4 Italy: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.4.1 Overview
    - 13.2.9.4.2 Italy: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.4.3 Italy: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.4.4 Italy: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.4.4.1 Biomarkers: Metabolomics 2019-2028
    - 13.2.9.4.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.2.9.4.4.3 Italy: Sepsis Diagnostics Market, by Molecular Diagnostics- Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.4.5 Italy: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.4.6 Italy: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.4.7 Italy: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.4.8 Italy: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 13.2.9.5 Spain: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.5.1 Overview
    - 13.2.9.5.2 Spain: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.5.3 Spain: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.5.4 Spain: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.5.4.1 Biomarkers: Metabolomics 2019-2028
    - 13.2.9.5.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.2.9.5.4.3 Spain: Sepsis Diagnostics Market, by Molecular Diagnostics- Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.5.5 Spain: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.5.6 Spain: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.5.7 Spain: Sepsis Diagnostics Market, by Pathogen- Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.5.8 Spain: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 13.2.9.6 Rest of Europe: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.6.1 Overview
    - 13.2.9.6.2 Rest of Europe: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.6.3 Rest of Europe: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.6.4 Rest of Europe: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.6.4.1 Biomarkers: Metabolomics 2019-2028
    - 13.2.9.6.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.2.9.6.4.3 Rest of Europe: Sepsis Diagnostics Market, by Molecular Diagnostics- Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.6.5 Rest of Europe: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.6.6 Rest of Europe: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.6.7 Rest of Europe: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.6.8 Rest of Europe: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
13.3 Asia Pacific: Sepsis Diagnostics Market
- 13.3.1 Overview
- 13.3.2 Asia Pacific: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
- 13.3.3 Asia Pacific: Sepsis Diagnostics Market, By Product, 2019-2028 (USD Million)
- 13.3.4 Asia Pacific: Sepsis Diagnostics Market, by Technology, 2019-2028 (USD Million)
  - 13.3.4.1 Biomarkers: Metabolomics 2019-2028
  - 13.3.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
  - 13.3.4.3 Asia Pacific Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
- 13.3.5 Asia Pacific: Sepsis Diagnostics Market, by Method, 2019-2028 (USD Million)
- 13.3.6 Asia Pacific: Sepsis Diagnostics Market, by Test Type, 2019-2028 (USD Million)
- 13.3.7 Asia Pacific: Sepsis Diagnostics Market, by Pathogen, 2019-2028 (USD Million)
- 13.3.8 Asia Pacific: Sepsis Diagnostics Market, By End User, 2019-2028 (USD Million)
- 13.3.9 Asia Pacific: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
  - 13.3.9.1 China: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.1.1 China: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.1.2 China: Sepsis Diagnostics Market, By Product, 2019-2028 (USD Million)
    - 13.3.9.1.3 China: Sepsis Diagnostics Market, by Technology, 2019-2028 (USD Million)
    - 13.3.9.1.3.1 Biomarkers: Metabolomics 2019-2028
    - 13.3.9.1.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.3.9.1.3.3 China Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.1.4 China: Sepsis Diagnostics Market, by Method, 2019-2028 (USD Million)
    - 13.3.9.1.5 China: Sepsis Diagnostics Market, by Test Type, 2019-2028 (USD Million)
    - 13.3.9.1.6 China: Sepsis Diagnostics Market, by Pathogen, 2019-2028 (USD Million)
    - 13.3.9.1.7 China: Sepsis Diagnostics Market, By End User, 2019-2028 (USD Million)
  - 13.3.9.2 Japan: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.2.1 Japan: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.2.2 Japan: Sepsis Diagnostics Market, By Product, 2019-2028 (USD Million)
    - 13.3.9.2.3 Japan: Sepsis Diagnostics Market, By Technology, 2019-2028 (USD Million)
    - 13.3.9.2.3.1 Biomarkers: Metabolomics 2019-2028
    - 13.3.9.2.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.3.9.2.3.3 Japan Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.2.4 Japan: Sepsis Diagnostics Market, By Method, 2019-2028 (USD Million)
    - 13.3.9.2.5 Japan: Sepsis Diagnostics Market, By Test Type, 2019-2028 (USD Million)
    - 13.3.9.2.6 Japan: Sepsis Diagnostics Market, By Pathogen, 2019-2028 (USD Million)
    - 13.3.9.2.7 Japan: Sepsis Diagnostics Market, By End User, 2019-2028 (USD Million)
  - 13.3.9.3 India: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.3.1 India: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.3.2 India: Sepsis Diagnostics Market, By Product, 2019-2028 (USD Million)
    - 13.3.9.3.3 India: Sepsis Diagnostics Market, By Technology, 2019-2028 (USD Million)
    - 13.3.9.3.3.1 Biomarkers: Metabolomics 2019-2028
    - 13.3.9.3.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.3.9.3.3.3 India Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.3.4 India: Sepsis Diagnostics Market, By Method, 2019-2028 (USD Million)
    - 13.3.9.3.5 India: Sepsis Diagnostics Market, By Test Type, 2019-2028 (USD Million)
    - 13.3.9.3.6 India: Sepsis Diagnostics Market, By Pathogen, 2019-2028 (USD Million)
    - 13.3.9.3.7 India: Sepsis Diagnostics Market, By End User, 2019-2028 (USD Million)
  - 13.3.9.4 Australia: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.4.1 Australia: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.4.2 Australia: Sepsis Diagnostics Market, By Product, 2019-2028 (USD Million)
    - 13.3.9.4.3 Australia: Sepsis Diagnostics Market, By Technology, 2019-2028 (USD Million)
    - 13.3.9.4.3.1 Biomarkers: Metabolomics 2019-2028
    - 13.3.9.4.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.3.9.4.3.3 Australia Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.4.4 Australia: Sepsis Diagnostics Market, By Method, 2019-2028 (USD Million)
    - 13.3.9.4.5 Australia: Sepsis Diagnostics Market, By Test Type, 2019-2028 (USD Million)
    - 13.3.9.4.6 Australia: Sepsis Diagnostics Market, By Pathogen, 2019-2028 (USD Million)
    - 13.3.9.4.7 Australia: Sepsis Diagnostics Market, By End User, 2019-2028 (USD Million)
  - 13.3.9.5 South Korea: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.5.1 South Korea: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.5.2 South Korea: Sepsis Diagnostics Market, By Product, 2019-2028 (USD Million)
    - 13.3.9.5.3 South Korea: Sepsis Diagnostics Market, By Technology, 2019-2028 (USD Million)
    - 13.3.9.5.3.1 Biomarkers: Metabolomics 2019-2028
    - 13.3.9.5.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.3.9.5.3.3 South Korea Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.5.4 South Korea: Sepsis Diagnostics Market, By Method, 2019-2028 (USD Million)
    - 13.3.9.5.5 South Korea: Sepsis Diagnostics Market, By Test Type, 2019-2028 (USD Million)
    - 13.3.9.5.6 South Korea: Sepsis Diagnostics Market, By Pathogen, 2019-2028 (USD Million)
    - 13.3.9.5.7 South Korea: Sepsis Diagnostics Market, By End User, 2019-2028 (USD Million)
  - 13.3.9.6 Rest of Asia Pacific: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.6.1 Rest of Asia Pacific: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.6.2 Rest of Asia Pacific: Sepsis Diagnostics Market, By Product, 2019-2028 (USD Million)
    - 13.3.9.6.3 Rest of Asia Pacific: Sepsis Diagnostics Market, By Technology, 2019-2028 (USD Million)
    - 13.3.9.6.3.1 Biomarkers: Metabolomics 2019-2028
    - 13.3.9.6.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.3.9.6.3.3 Rest of APAC Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.6.4 Rest of Asia Pacific: Sepsis Diagnostics Market, By Method, 2019-2028 (USD Million)
    - 13.3.9.6.5 Rest of Asia Pacific: Sepsis Diagnostics Market, By Test Type, 2019-2028 (USD Million)
    - 13.3.9.6.6 Rest of Asia Pacific: Sepsis Diagnostics Market, By Pathogen, 2019-2028 (USD Million)
    - 13.3.9.6.7 Rest of Asia Pacific: Sepsis Diagnostics Market, By End User, 2019-2028 (USD Million)
13.4 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts To 2028
- 13.4.1 Overview
- 13.4.2 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
- 13.4.3 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
- 13.4.4 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  - 13.4.4.1 Biomarkers: Metabolomics 2019-2028
  - 13.4.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
  - 13.4.4.3 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
- 13.4.5 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
- 13.4.6 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
- 13.4.7 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
- 13.4.8 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
- 13.4.9 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
  - 13.4.9.1 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 13.4.9.1.1 Overview
    - 13.4.9.1.2 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 13.4.9.1.3 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    - 13.4.9.1.4 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
    - 13.4.9.1.4.1 Biomarkers: Metabolomics 2019-2028
    - 13.4.9.1.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.4.9.1.4.3 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
    - 13.4.9.1.5 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 13.4.9.1.6 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
    - 13.4.9.1.7 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
    - 13.4.9.1.8 UAE: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  - 13.4.9.2 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 13.4.9.2.1 Overview
    - 13.4.9.2.2 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 13.4.9.2.3 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    - 13.4.9.2.4 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
    - 13.4.9.2.4.1 Biomarkers: Metabolomics 2019-2028
    - 13.4.9.2.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.4.9.2.4.3 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
    - 13.4.9.2.5 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 13.4.9.2.6 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
    - 13.4.9.2.7 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
    - 13.4.9.2.8 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  - 13.4.9.3 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 13.4.9.3.1 Overview
    - 13.4.9.3.2 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 13.4.9.3.3 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    - 13.4.9.3.4 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
    - 13.4.9.3.4.1 Biomarkers: Metabolomics 2019-2028
    - 13.4.9.3.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.4.9.3.4.3 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
    - 13.4.9.3.5 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 13.4.9.3.6 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
    - 13.4.9.3.7 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
    - 13.4.9.3.8 South Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  - 13.4.9.4 Rest of Middle East and Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 13.4.9.4.1 Overview
    - 13.4.9.4.2 Rest of Middle East and Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 13.4.9.4.3 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    - 13.4.9.4.4 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
    - 13.4.9.4.4.1 Biomarkers: Metabolomics 2019-2028
    - 13.4.9.4.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.4.9.4.4.3 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
    - 13.4.9.4.5 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 13.4.9.4.6 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
    - 13.4.9.4.7 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
    - 13.4.9.4.8 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
13.5 South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028
- 13.5.1 Overview
- 13.5.2 South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
- 13.5.3 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
- 13.5.4 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  - 13.5.4.1 Biomarkers: Metabolomics 2019-2028
  - 13.5.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
  - 13.5.4.3 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
- 13.5.5 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
- 13.5.6 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
- 13.5.7 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
- 13.5.8 South & Central America: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
- 13.5.9 South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
  - 13.5.9.1 Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 13.5.9.1.1 Overview
    - 13.5.9.1.2 Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 13.5.9.1.3 Brazil: Sepsis Diagnostics Market Revenue and Forecasts To 2028, By Product (US$ Million)
- 13.5.9

敗血症診断薬の2028年までの市場予測-製品、技術、手法、検査タイプ、病原体、エンドユーザーごとの世界分析

Sepsis Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, Technology, Method, Test Type, Pathogen, and End User

目次

第1章イントロダクション

第2章重要なポイント

第3章調査手法

第4章敗血症診断薬市場- 市場情勢

第5章敗血症診断市場- 主な市場力学

第6章敗血症診断薬市場-世界分析

第7章：敗血症診断薬の世界市場収益と2028年までの予測-製品別

第8章敗血症診断薬市場の収益と2028年までの予測（技術編

第9章敗血症診断の市場収益と2028年までの予測- 方法

第10章敗血症診断薬市場の収益と2028年までの予測（検査タイプ別

第11章敗血症診断薬市場の収益と2028年までの予測- 病原体

第12章敗血症診断薬市場の収益と2028年までの予測（エンドユーザー編

第13章敗血症診断の世界市場の収益と2028年までの予測-地域別分析

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Key Takeaways

3. Research Methodology

4. Sepsis Diagnostics Market - Market Landscape

5. Sepsis Diagnostics Market - Key Market Dynamics

6. Sepsis Diagnostics Market- Global Analysis

7. Global Sepsis Diagnostics Market Revenue and Forecasts To 2028- by Product

8. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Technology

9. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Method

10. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Test Type

11. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Pathogen

12. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - End User

13. Global Sepsis Diagnostics Market Revenue and Forecasts to 2028 - Geographical Analysis

敗血症診断薬の2028年までの市場予測-製品、技術、手法、検査タイプ、病原体、エンドユーザーごとの世界分析

Sepsis Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, Technology, Method, Test Type, Pathogen, and End User

目次

第1章 イントロダクション

第2章 重要なポイント

第3章 調査手法

第4章 敗血症診断薬市場- 市場情勢

第5章 敗血症診断市場- 主な市場力学

第6章 敗血症診断薬市場-世界分析

第7章：敗血症診断薬の世界市場収益と2028年までの予測-製品別

第8章 敗血症診断薬市場の収益と2028年までの予測（技術編

第9章 敗血症診断の市場収益と2028年までの予測- 方法

第10章 敗血症診断薬市場の収益と2028年までの予測（検査タイプ別

第11章 敗血症診断薬市場の収益と2028年までの予測- 病原体

第12章 敗血症診断薬市場の収益と2028年までの予測（エンドユーザー編

第13章 敗血症診断の世界市場の収益と2028年までの予測-地域別分析

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Key Takeaways

3. Research Methodology

4. Sepsis Diagnostics Market - Market Landscape

5. Sepsis Diagnostics Market - Key Market Dynamics

6. Sepsis Diagnostics Market- Global Analysis

7. Global Sepsis Diagnostics Market Revenue and Forecasts To 2028- by Product

8. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Technology

9. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Method

10. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Test Type

11. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Pathogen

12. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - End User

13. Global Sepsis Diagnostics Market Revenue and Forecasts to 2028 - Geographical Analysis

第1章イントロダクション

第2章重要なポイント

第3章調査手法

第4章敗血症診断薬市場- 市場情勢

第5章敗血症診断市場- 主な市場力学

第6章敗血症診断薬市場-世界分析

第8章敗血症診断薬市場の収益と2028年までの予測（技術編

第9章敗血症診断の市場収益と2028年までの予測- 方法

第10章敗血症診断薬市場の収益と2028年までの予測（検査タイプ別

第11章敗血症診断薬市場の収益と2028年までの予測- 病原体

第12章敗血症診断薬市場の収益と2028年までの予測（エンドユーザー編

第13章敗血症診断の世界市場の収益と2028年までの予測-地域別分析